H. Ralph Snodgrass - Jun 30, 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
PRES./CHIEF SCIENTIFIC OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Jun 30, 2021
Transactions value $
$6,601
Form type
4
Date filed
7/2/2021, 04:10 PM
Next filing
Aug 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $6.6K +3.39K +3.87% $1.95 91.1K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).